Clinical Trial Update: Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial in rheumatoid arthritis investigating TNF-alpha–induced pre-B cell bone marrow emigrants, which has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: University of Pittsburgh | Conditions: Rheumatoid Arthritis | Phase 4 | Status: WITHDRAWN